Holds 4 active US DMFs and 4 valid CEPs for azithromycin, filing since 2005. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 18 markets.
EDQM certificate database
FDA, List of Drug Master Files
Holds 4 active US DMFs and 4 valid CEPs for azithromycin, filing since 2005. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 18 markets.
Holds 2 active US DMFs for azithromycin, filing since 2012. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 30 markets.
Holds one active US DMF for azithromycin, filing since 2020. Its 2023 FDA inspection closed as NAI, and its GMP is recognised in 3 markets.
Holds one active US DMF for azithromycin, filing since 2020. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 1 market.
Holds 4 active US DMFs for azithromycin, filing since 2005. Its 2022 FDA inspection closed as VAI.
Holds one active US DMF for azithromycin, filing since 2016. Its GMP is recognised in 1 market.
Holds one active US DMF for azithromycin, filing since 2013.
Holds 2 active US DMFs for azithromycin, filing since 2013. Its 2024 FDA inspection closed as OAI, and its GMP is recognised in 1 market.
The names are listed below. The filings, inspection history and GMP certificates behind each one are available with a free account.
This page filters the worldwide Azithromycin manufacturer list to companies based in India. The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Read the full method.
Tell us which markets you need to file in. These suppliers come back tiered for those markets, with the price corridor and an RFI sheet.
Start for free